Interaction between monocytes and vascular endothelial cells induces adrenomedullin production.
Adrenomedullin (AM), a potent vasodilator peptide, has natriuretic effects, and its plasma concentration is elevated in cardiovascular diseases. In the present study, we investigated the induction of AM expression due to interactions between THP-1 cells (human monocytic cell line) and human umbilical cord vein endothelial cells (HUVECs). AM levels in the culture medium were measured by radioimmunoassay. The luciferase vector containing the 5'-flanking region of the human AM gene was transfected into either HUVECs or THP-1 cells. Addition of THP-1 cells to HUVECs for 48 h induced marked increases in AM levels, which were 16-fold higher than those of HUVECs alone. Luciferase vectors containing the 5'-flanking region of human AM gene (pLCF-1534) were transferred into THP-1 cells or HUVECs. Addition of THP-1 cells to pLCF-1534-transfected HUVECs induced an increase in luciferase activity in cell lysates, which was 5-fold higher than that of the transfected HUVECs alone. In contrast, the luciferase activity of lysates from pLCF-1534-transfected THP-1 cells was not affected by coculture with HUVECs. A separate coculture experiment revealed that direct contact of THP-1 cells and HUVECs contributed to enhanced AM production in the cocoulture. Co-incubation of the cell membrane fraction from THP-1 cells augmented AM production by HUVECs. Both anti-interleukin (IL)-1alpha antibody and IL-1 receptor antagonist significantly inhibited AM production in the cocultures. The cell-to-cell interaction between monocytes and HUVECs induces AM production by HUVECs, which may play an important role in the pathogenesis of vascular disorders.
Hojo
Y
Y
Department of Cardiology, Jichi Medical School, Minamikawachi-machi, 329-0498, Tochigi, Japan
Ikeda
U
U
Ohya
K
K
Ichida
M
M
Kario
K
K
Takahashi
M
M
Ikeda
M
M
Minota
S
S
Isumi
Y
Y
Minamino
N
N
Ishimitsu
T
T
Shimada
K
K
D053607:Adrenomedullin; D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D000954:Antigens, Surface / Q000502:physiology; D001161:Arteriosclerosis / Q000209:etiology / Q000473:pathology; D002448:Cell Adhesion; D002450:Cell Communication; D002462:Cell Membrane / Q000502:physiology; D002478:Cells, Cultured; D018920:Coculture Techniques; D004730:Endothelium, Vascular / Q000166:cytology* / Q000378:metabolism; D005786:Gene Expression Regulation / Q000187:drug effects; D017930:Genes, Reporter; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein; D007375:Interleukin-1 / Q000037:antagonists & inhibitors; D007948:Leukemia, Monocytic, Acute / Q000473:pathology; D008156:Luciferases / Q000096:biosynthesis / Q000235:genetics; D051379:Mice; D009000:Monocytes / Q000502:physiology*; D010455:Peptides / Q000235:genetics / Q000378:metabolism*; D011993:Recombinant Fusion Proteins / Q000096:biosynthesis; D012795:Sialoglycoproteins / Q000494:pharmacology; D014162:Transfection; D014407:Tumor Cells, Cultured; D014664:Vasodilation / Q000502:physiology
D000911:Antibodies, Monoclonal; D000954:Antigens, Surface; C507763:IL1RN protein, human; C507764:Il1rn protein, mouse; D053590:Interleukin 1 Receptor Antagonist Protein; D007375:Interleukin-1; D010455:Peptides; D011993:Recombinant Fusion Proteins; D012795:Sialoglycoproteins; D053607:Adrenomedullin; D008156:Luciferases